Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Peter J. Solomon Company, LLC et al v. ADC Products (UK) Limited
Case Number:
1:14-cv-04086
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
May 10, 2017
Solomon Gets Nearly $5M In Spirogen Sale Dispute
A New York federal judge on Wednesday awarded investment banking advisory firm Peter J. Solomon Co. LP nearly $5 million in fees and interest from the $200 million sale of the British biotech formerly known as Spirogen Ltd. to an to an AstraZeneca PLC subsidiary.
-
July 23, 2015
Biotech Says Solomon Isn't Owed $3.7M For AstraZeneca Deal
The British biotech formerly known as Spirogen Ltd. pressed a New York federal judge Wednesday to ditch investment banking advisory firm Peter J. Solomon Co.'s suit seeking fees from the company's $200 million sale to an AstraZeneca PLC subsidiary, saying the firm wasn't involved.
-
July 08, 2015
Biotech Says Solomon Wasn't Involved In AstraZeneca Deal
A British biotech company, formerly known as Spirogen Ltd., told a New York federal judge Wednesday that investment banking advisory firm Peter J. Solomon Co. had never worked on its $200 million sale to an AstraZeneca PLC subsidiary, despite the adviser's claim.